NovaBay Pharmaceuticals Inc. Shares Fall 1.3% Below Previous 52-Week Low - Market Mover
The shares fell 1.3% lower than its previous 52-week low of $0.40, with trading volume lower than its 30 day average
Dec 29, 2021 by Kwhen Finance Editors
NovaBay Pharmaceuticals Inc. (NBY) shares closed 1.3% lower than its previous 52 week low, giving the company a market cap of $18M. The stock is currently down 41.0% year-to-date, down 43.7% over the past 12 months, and down 87.5% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%.
Trading Activity
- Trading volume this week was 37.2% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| NovaBay Pharmaceuticals Inc. | -3.9 | -41.0 | -43.7 | -76.3 | 5.9 |
| Dow Jones Industrial Average | 0.3 | 20.7 | 22.2 | -1.2 | 22.6 |
| S&P 500 Index | -0.1 | 29.4 | 31.1 | -1.1 | 31.1 |
| Health Care | -0.3 | 23.4 | 25.0 | 0.2 | 27.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -383.5%
- The company's stock price performance over the past 12 months lags the peer average by -525.9%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| NovaBay Pharmaceuticals Inc. | NBY | 0 | -41.0 | -43.7 | -76.3 | 5.9 |
| Peer Avg | N/A | 15.3 | 14.5 | 10.3 | -32.9 | 17.8 |
| Johnson & Johnson | JNJ | 25.0 | 10.5 | 14.1 | -4.4 | 14.3 |
| SIGA Technologies Inc | SIGA | 36.2 | 10.3 | 9.3 | ||
| Oragenics Inc. | OGEN | 0 | 5.3 | 10.0 | -74.1 | 13.5 |
| NanoViricides Inc. | NNVC | 0 | 31.7 | 7.7 | -53.2 | 43.2 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: